Cargando…
T Cell Epitope Immunotherapy Induces a CD4(+) T Cell Population with Regulatory Activity
BACKGROUND: Synthetic peptides, representing CD4(+) T cell epitopes, derived from the primary sequence of allergen molecules have been used to down-regulate allergic inflammation in sensitised individuals. Treatment of allergic diseases with peptides may offer substantial advantages over treatment w...
Autores principales: | Verhoef, Adrienne, Alexander, Clare, Kay, A. Barry, Larché, Mark |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069669/ https://www.ncbi.nlm.nih.gov/pubmed/15783262 http://dx.doi.org/10.1371/journal.pmed.0020078 |
Ejemplares similares
-
Immunoglobulin E–independent Major Histocompatibility Complex–restricted T Cell Peptide Epitope–induced Late Asthmatic Reactions
por: Haselden, Brigitte M., et al.
Publicado: (1999) -
Self and microbiota-derived epitopes induce CD4(+) T cell anergy and conversion into CD4(+)Foxp3(+) regulatory cells
por: Kuczma, Michal P., et al.
Publicado: (2020) -
Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression
por: Campbell, John D., et al.
Publicado: (2009) -
Immunotherapy with Allergen Peptides
por: Larché, Mark
Publicado: (2007) -
Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
por: Chen, Guojiang, et al.
Publicado: (2009)